GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Future Policy Benefits

Invex Therapeutics (ASX:IXC) Future Policy Benefits


View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Invex Therapeutics (ASX:IXC) Business Description

Traded in Other Exchanges
N/A
Address
38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.